Health care stocks fell Wednesday afternoon, with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.4%.
The iShares Biotechnology ETF (IBB) declined 1.5%.
In corporate news, Jaguar Health (JAGX) shares fell more than 6% after the company signed securities purchase agreements to issue up to nearly $3.5 million in convertible promissory notes to Chief Executive Officer Lisa Conte, three board members, seven other senior executives and selected investors.
Atea Pharmaceuticals (AVIR) shareholder Radoff-JEC Group said in an open letter Wednesday that it plans to nominate three directors at the company's annual general meeting as it raised concerns about Atea's stock price performance, strategy and governance practices. Atea shares were down 0.6%.
Wave Life Sciences (WVE) shares jumped past 6% after the company reported "positive" 48-week data from a phase 2 trial of its WVE-N531 drug candidate in boys with Duchenne muscular dystrophy.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。